DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,947,000 | -4.8% | 115,259 | -17.9% | 0.00% | 0.0% |
| Q4 2020 | $3,095,000 | +16.5% | 140,471 | -4.9% | 0.00% | 0.0% |
| Q3 2020 | $2,656,000 | -27.9% | 147,653 | +1.8% | 0.00% | -50.0% |
| Q2 2020 | $3,683,000 | +70.8% | 144,990 | +23.5% | 0.00% | +33.3% |
| Q1 2020 | $2,156,000 | -17.9% | 117,375 | -1.5% | 0.00% | +50.0% |
| Q4 2019 | $2,625,000 | +78.1% | 119,175 | +16.1% | 0.00% | +100.0% |
| Q3 2019 | $1,474,000 | +40.0% | 102,675 | +53.6% | 0.00% | 0.0% |
| Q2 2019 | $1,053,000 | +28.9% | 66,839 | +19.8% | 0.00% | 0.0% |
| Q1 2019 | $817,000 | -29.6% | 55,800 | -48.6% | 0.00% | -50.0% |
| Q4 2018 | $1,161,000 | -15.8% | 108,587 | +20.1% | 0.00% | 0.0% |
| Q3 2018 | $1,379,000 | +97.6% | 90,387 | +58.6% | 0.00% | +100.0% |
| Q2 2018 | $698,000 | +78.1% | 57,000 | +39.0% | 0.00% | 0.0% |
| Q1 2018 | $392,000 | +5.9% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $370,000 | +56.8% | 41,000 | 0.0% | 0.00% | – |
| Q3 2017 | $236,000 | +81.5% | 41,000 | 0.0% | 0.00% | – |
| Q2 2017 | $130,000 | -6.5% | 41,000 | 0.0% | 0.00% | – |
| Q1 2017 | $139,000 | +17.8% | 41,000 | 0.0% | 0.00% | – |
| Q4 2016 | $118,000 | -51.0% | 41,000 | 0.0% | 0.00% | – |
| Q3 2016 | $241,000 | +95.9% | 41,000 | 0.0% | 0.00% | – |
| Q2 2016 | $123,000 | -44.1% | 41,000 | 0.0% | 0.00% | – |
| Q1 2016 | $220,000 | -54.8% | 41,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $487,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|